News
Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood ...
In February 2025 Harbour BioMed announced that the IND application for HBM9378 (SKB378), a TSLP-targeting monoclonal antibody ...
Cedars-Sinai investigators have developed an investigational therapy that brought a significant number of patients with ...
Elanco Animal Health Incorporated announced today that its Canine Parvovirus Monoclonal Antibody (CPMA) has become the first US Department of Agriculture conditionally approved treatment that targets ...
A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...
Patients with bronchiectasis and a Pseudomonas aeruginosa infection receiving gremubamab, a bispecific monoclonal antibody, ...
Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne ...
ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...
These monoclonal antibodies have different mechanisms of action, ranging from interleukin-6 inhibition to complement inhibition, all of which are valid for NMOSD. Therefore, the rationale for choosing ...
Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...
WATERTOWN, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the ...
Similar antibodies can be made from animal sources and used in humans. Why is hyperimmune immunoglobulin a possible treatment for COVID-19? Hyperimmune immunoglobulin products contain high levels of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results